Prognostic significance of vascular endothelial growth factor, basic fibroblastic growth factor, and microvessel density and their relation to cell proliferation in B-cell non-Hodgkin's lymphoma

Annals of Diagnostic Pathology

Volumn 14, Issue 5, 2010, Pages 321-327

  Alshenawy, Hanan Alsaeid ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Angiogenesis; B cell non Hodgkin's lymphoma; b FGF; Microvessel density; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CD34 ANTIBODY; FIBROBLAST GROWTH FACTOR; KI 67 ANTIGEN; VASCULOTROPIN;

AGGRESSIVENESS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER STAGING; CELL PROLIFERATION; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHADENITIS; LYMPHOBLASTOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MICROVASCULATURE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; ANTIGENS, CD34; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOMA, B-CELL; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956886916     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2009.12.011     Document Type: Article

References (33)

1. Koster A., van Krieken J.H., and Mackenzie M.A. Increased vascularization predicts favorable outcome in follicular lymphoma Clin Cancer Res 11 2005 154 161
2. Francesco B., Lisa F., and Patrizia M. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma Blood 2000
3. Salven P., Orpana A., and Teerenhovi L. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients Blood 96 2000 3712 3718
4. Mangi M.H., and Newland A.C. Angiogenesis and angiogenic mediators in hematological malignancies Br J Haematol 111 2000 43 51
5. Scappaticci F.A. Mechanisms and future directions for angiogenesis-based cancer therapies J Clin Oncol 20 2002 3906 3927
6. Eunice S., Julie T., and Yan W. Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo Blood 104 2004 2893 2902
7. Jia R., Elizabeth H., and Pouneh K. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma AACR-NCI-EORTC international conference. Molecular targets and cancer therapeutics. Boston, MA, Nov 15-19 2009
8. William T., Lynne R., and Yvette F. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies Cancer Res 59 1999 728 733
9. Ribatti D., Vacca A., and Nico B. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study Eur J Haematol 56 1996 45 53 (Pubitemid 26075594)
10. Perez-Atayde A.R., Sallan S.E., and Tedrow U. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia Am J Pathol 150 1997 815 821
11. Dita G., Shuchun Z., and Robert J. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes Am J Pathol 170 2007 1362 1369
12. Petri S., Lasse T., and Heikki J. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma Blood 94 1999 3334 3339
13. Pazga I., Zimra Y., and Tzabar C. Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma Br J Cancer 86 2002 1770 1775
14. Juczewska M., Chyczewska E., and Naumnik W. Endothelial cells and angiogenesis intensity in lung cancer Folia Histochem Cytobiol 39 2001 253 258
15. Wróbel T., Mazur G., Surowiak P., and Dzie Giel P. Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of multiple myeloma (MM) patients Eur J Int Med 14 2003 98 100 (Pubitemid 36457951)
16. Usnarska-Zubkiewicz L., Mazur G., and Wróbel T. Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma (in Polish) Pol Arch Med Wewn 110 2003 719 724 (Pubitemid 36994252)
17. Grzegorz M., Tomasz W., and Piotr D. Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non Hodgkin's lymphoma Folia Histochem Cytobiol 42 2004 241 243
18. Poon R.T., Fan S.T., and Wong J. Clinical implications of circulating angiogenic factors in cancer patients J Clin Oncol 19 2001 1207 1225
19. Harris N.L., Jaffe E.S., and Diebold J. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airline House, Virginia J Clin Oncol 17 1999 3835 3849
20. Lister T.A., and Crowdther D. Staging for Hodgkin's disease Semin Oncol 17 1990 696 703
21. Yiangou C., Gomm J.J., and Coope R.C. Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance Br J Cancer 75 1997 28 33 (Pubitemid 27007269)
22. Nardone G., Staibano S., and Rocco A. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis Gut 44 1999 789 799
23. Ribatti D., Vacca A., and Marzullo A. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas Int J Cancer 15 2000 171 175
24. Ho C.L., Sheu L.F., and Li C.Y. Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma Appl Immunohistochem Mol Morphol 10 2002 316 321
25. Berthold S.M.D., Andreas C.M.D., and Daniela H. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas N Engl J Med 351 2004 250 259
26. Yamazaki K., Nagao T., and Yamaguchi T. Expression of basic fibroblast growth factor (FGF-2)-associated with tumor proliferation in human pancreatic carcinoma Virchow Arch 431 1997 95 101
27. Blanckaert V.D., Hebbar M., and Louchez M.M. Basic fibroblast growth factor receptors and their prognostic value in human breast cancer Clin Cancer Res 4 1998 2939 2947
28. Menzel T., Rahman Z., and Calleja E. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine Blood 87 1996 1056 1063
29. Gruber G., Schwarzmeier J.D., and Shehata M. Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia Blood 94 1999 1077 1085
30. Sezer O., Jakob C., and Eucker J. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma Eur J Haematol 66 2001 83 88
31. Ridell B., and Norrby K. Intratumoral microvascular density in malignant lymphomas of B-cell origin APMIS 109 2001 66 72
32. Arias V., and Soares F.A. Vascular density (tumor angiogenesis) in non-Hodgkin's lymphomas and florid follicular hyperplasia: a morphometric study Leuk Lymphoma 40 2000 157 166
33. Kumar S., Gertz M.A., and Dispenzieri A. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy Bone Marrow Transplant 34 2004 235 239